Fig. 2From: A novel near-infrared EGFR targeting probe for metastatic lymph node imaging in preclinical mouse modelsStudy of molecular docking. (a) HER1 and Lapatinib with binding energy − 9.2 kcal/mol. (b) HER1 and LP-S with binding energy − 8.56 kcal/mol. (c) HER2 and Lapatinib with binding energy − 10.64 kcal/mol. (d) HER2 and LP-S with binding energy − 10.19 kcal/molBack to article page